# Azithromycin for Child Survival in Niger: Delivery Trial

> **NCT04774991** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 10925 (actual)

## Conditions studied

- Mortality
- Child Health
- Implementation

## Interventions

- **DRUG:** Azithromycin for Oral Suspension

## Key facts

- **NCT ID:** NCT04774991
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-28
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 10925 (ACTUAL)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774991, "Azithromycin for Child Survival in Niger: Delivery Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04774991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*